Colchicine, an anti-rheumatic agent, as a potential compound for the treatment of COVID-19

Carlo Perricone; Elena Bartoloni; Roberto Gerli

Streszczenie

1/2021

Colchicine, an anti-rheumatic agent, as a potential compound for the treatment of COVID-19

Carlo Perricone ¹

,

Elena Bartoloni ¹

,

Roberto Gerli ¹

Rheumatology Unit, Department of Medicine, University of Perugia, Italy

Data publikacji online: 2021/09/08

Pełna treść artykułu

AMA

Perricone C, Bartoloni E, Gerli R. Colchicine, an anti-rheumatic agent, as a potential compound for the treatment of COVID-19. Reumatologia/Rheumatology Supplements. 2021:261-264.

APA

Perricone, C., Bartoloni, E., & Gerli, R. (2021). Colchicine, an anti-rheumatic agent, as a potential compound for the treatment of COVID-19. Reumatologia/Rheumatology Supplements, 261-264.

Chicago

Perricone, Carlo, Elena Bartoloni, and Roberto Gerli. 2021. "Colchicine, an anti-rheumatic agent, as a potential compound for the treatment of COVID-19". Reumatologia/Rheumatology Supplements: 261-264.

Harvard

Perricone, C., Bartoloni, E., and Gerli, R. (2021). Colchicine, an anti-rheumatic agent, as a potential compound for the treatment of COVID-19. Reumatologia/Rheumatology Supplements, pp.261-264.

MLA

Perricone, Carlo et al. "Colchicine, an anti-rheumatic agent, as a potential compound for the treatment of COVID-19." Reumatologia/Rheumatology Supplements, 2021, pp. 261-264.

Vancouver

Perricone C, Bartoloni E, Gerli R. Colchicine, an anti-rheumatic agent, as a potential compound for the treatment of COVID-19. Reumatologia/Rheumatology Supplements. 2021:261-264.

Streszczenie

Colchicine, an anti-rheumatic agent, as a potential compound for the treatment of COVID-19

Udostępnij

Zintergrowane z